✦ LIBER ✦

Correction:Occurrence of leukaemia following gene therapy of X-linked SCID

✍ Scribed by Kohn, Donald B. ;Sadelain, Michel ;Glorioso, Joseph C.

Book ID: 109947068
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 47 KB
Volume: 3
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrc1236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Application of HSVtk suicide gene to X-S

Application of HSVtk suicide gene to X-SCID gene therapy: Ganciclovir treatment offsets gene corrected X-SCID B cells

✍ Toru Uchiyama; Satoru Kumaki; Yoshinori Ishikawa; Masafumi Onodera; Miki Sato; W 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Ex vivo γc gene therapy successful in X-

Ex vivo γc gene therapy successful in X-linked SCID

✍ Greener, Mark 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 152 KB

Sustained Correction of X-Linked Severe

Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy

✍ Hacein-Bey-Abina, Salima; Le Deist, Françoise; Carlier, Frédérique; Bouneaud, Cé 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 211 KB

Gene Therapy of Human Severe Combined Im

Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease

✍ Cavazzana-Calvo, M. 📂 Article 📅 2000 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 490 KB

Gene Therapy of X-Linked Severe Combined

Gene Therapy of X-Linked Severe Combined Immunodeficiency

✍ Salima Hacein-Bey-Abina; Alain Fischer; Marina Cavazzana-Calvoa 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 75 KB

French gene therapy group reports on the

French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID) : Position statement from the European Society of Gene Therapy (ESGT)

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

## Position statement from the European Society of Gene Therapy (ESGT) Background News of a serious adverse event in a clinical trial of gene therapy for inherited, X chromosome-linked Severe Combined Immunodeficiency (X-SCID) was made public on October 2, 2002, by the group of French scientists p